Drug recall
Pentazocine and Naloxone Hydrochlorides Tablets, USP; 50 mg (base) 0.5 mg (base), 100 tablet bottles, Rx only…
FDA recall event 47798 · Class III · Actavis Totowa LLC
Key facts
| Event ID | 47798 |
|---|---|
| Recall numbers | D-262-2008 |
| Recalling firm | Actavis Totowa LLC |
| Product type | Drugs |
| Products | Pentazocine and Naloxone Hydrochlorides Tablets, USP; 50 mg (base) 0.5 mg (base), 100 tablet bottles, Rx only, Actavis Totowa LLC, Totowa, NJ, 97512 USA ---- also labeled as Amide Pharmaceutical… |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Superpotent; Naloxone (9 month stability) |
| Initiation date | May 7, 2008 |
| Termination date | Aug 23, 2010 |
| City | Totowa |
| State | NJ |
| Country | United States |
| FEI number | 2244683 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports